Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Integrin alphavbeta3 antagonist findings presented by Genentech team at AHA

Nov. 12, 1999

Avigen reports advances in gene therapy for hemophilia A

Nov. 12, 1999

INTEGRITI study will evaluate fibrinogen antagonist/thrombolytic combination

Nov. 11, 1999

Studies on absorption of ME-3229 in rat intestinal segments

Nov. 10, 1999

Cromafiban stands head and shoulders above others in its class

Nov. 10, 1999

Soluble CD39: novel antiplatelet agent enters the pipeline at Immunex

Nov. 9, 1999

Angiomax available through expanded access study in HIT/HITTS patients

Nov. 3, 1999

3-D's new protease (thrombin) inhibitors

Nov. 2, 1999

Corvas begins second phase II trial for anticoagulant rNAPc2

Nov. 2, 1999

RWJ-56110: design, synthesis and characterization of new peptidomimetic PAR-1 antagonist

Oct. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...